Human Interleukin 9,IL-9 ELISA KIT
- Known as:
- Human Interleukin 9,Interleukin-9 Enzyme-linked immunosorbent assay test KIT
- Catalog number:
- csb-e04642h
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Cusabio Elisa
- Gene target:
- Human Interleukin 9 IL-9 ELISA KIT
Ask about this productRelated genes to: Human Interleukin 9,IL-9 ELISA KIT
- Gene:
- IL9 NIH gene
- Name:
- interleukin 9
- Previous symbol:
- -
- Synonyms:
- IL-9, HP40, P40
- Chromosome:
- 5q31.1
- Locus Type:
- gene with protein product
- Date approved:
- 1990-06-11
- Date modifiied:
- 2016-10-05
Related products to: Human Interleukin 9,IL-9 ELISA KIT
Related articles to: Human Interleukin 9,IL-9 ELISA KIT
- Infection by the Zika virus (ZIKV) results in a broad spectrum of disease ranging from mild to severe neurological complications. The clinical features of ZIKV human infection are similar in pregnant women compared with nonpregnant women, though symptomatic infection is more frequent during pregnancy. However, little is known about the profile of systemic immune mediators during ZIKV infection in pregnant women. To characterize immunological mediators in ZIKV infection during pregnancy, we measured the levels of circulating cytokines, chemokines, and growth factors by multiplex immunoassay in 32 pregnant women, categorized according to trimesters of pregnancy. ZIKV-infected pregnant women presented higher levels of the cytokines IL-1β, IL-6, TNF-α, IL-12, IFN-γ, IL-17, IL-1Ra, IL-4, IL-5, IL-9, and IL-10 than healthy women. Moreover, a set of pro-inflammatory biomarkers, including IL-1β, IL-6, TNF-α, IL-12, IFN-γ, CCL11, and G-CSF, showed significant increased levels in the gestational second trimester than in the first trimester, which remains elevated throughout the third trimester. In conclusion, our findings indicate that ZIKV human infection during pregnancy triggers a strong and broad systemic inflammatory response, and during the viral infection, their kinetics of the production varied according to the gestational age. - Source: PubMed
Publication date: 2026/02/05
Teixeira-Carvalho AndréaAntonelli Lis Ribeiro do VallePontes Gemilson SoaresPrado Roberta OliveiraFrias Bruna Stefânia Dinizde Carvalho Kétyllen Reis AndradeCampi-Azevedo Ana CarolinaCoelho-Dos-Reis Jordana Grazielado Nascimento Valdinete AlvesMonteiro Dana Cristina da Silvada Silva Marineide SouzaAbdalla Lígia FernandesSantos João Hugo AbdallaGomes Matheus de SouzaAmaral Laurence RodriguesAlpoim Patrícia NessrallaGodoi Lara CarvalhoDusse Luci M SNaveca Felipe GomesMartins-Filho Olindo Assis - The longitudinal interplay between leukocyte telomere length (LTL) and persistent immune activation after mild SARS-CoV-2 infection remains incompletely characterized. - Source: PubMed
Publication date: 2026/06/30
Dos Santos Daiane RenataRosa Daniela Valadão FreitasLeite Arnaldo SantosMarinho Carolina CoimbraBicalho Maria Aparecida CamargosRomano-Silva Marco Aureliode Miranda Débora MarquesBarros Alexandre Guimarães de Almeida - Prenatal exposure to air pollution is linked to impaired infant lung function. At-risk infants, such as those born to mothers with asthma during pregnancy, may be more vulnerable. - Source: PubMed
Publication date: 2026/07/13
Da Silva Sena Carla RebecaGorlanova OlgaKünstle NoëmiCosta Gomes Gabriela MartinsMarten AndreaSchulzke SvenWyler FlorianMurphy Vanessa ERobinson Paul DSly Peter DUsemann JakobStoecklin BenjaminYammine SophieLatzin PhilippSinues PabloGibson Peter GKarmaus Wilfried J JMorgan Geoffrey GGopi Karthikde Hoogh KeesRöösli MartinCollison Adam MMattes JoergFrey Urs - Recent reports indicate that stem cell spheres might offer enhanced therapeutic benefits by promoting cell engraftment ability, stemness, angiogenesis, and chemotaxis. Hence, we investigated whether amniotic fluid stem cells (AFSC) spheres could provide therapeutic benefits in stress urinary incontinence (SUI) due to their urethral sphincter-specific commitment. The isolated human AFSCs were characterized by flow-cytometry-based immunophenotyping and their multidifferentiation potential (osteo-, adipo-, and chondrogenic lineages). Time-dependent (>12, 16∼20, and 48 hours) culture conditions for AFSCsphere formation were optimized. Urodynamic parameters, including leak point pressure (LPP) and intercontraction interval (ICI), were determined. hAFSCsphere with ∼150 m diameter with minimal core necrosis at 16∼20 hours was found optimal for therapeutic application in the pudendal nerve injury-induced SUI rat model. The AFSCs demonstrated mesenchymal stem cell characteristics and multi-differentiation capabilities with retained levels of pluripotency and neural progenitor markers, SOX2 and nestin, respectively. Compared to AFSC, the AFSCsphere group showed superior LPP and ICI in rats; however, with either modest, relatively low, or unchanged levels of myogenic-lineage genes (, myoD, myogenin, and desmin) between them. Bladder and external urethral sphincter histologic architecture were also improved. Notably, AFSCsphere showed the elevated levels of secetome (VEGF, IL-6, IL-8, IL-9, and MIP-1) than AFSC, when compared to control. This could be attributed to non-myogenic pathways, such as paracrine dominance, including anti-inflammatory, angiogenic, or neurotrophic. Conclusively, our study revealed that AFSCsphere may improve urodynamics despite a significant increase in myogenic regulatory factor expression. Therefore, future studies should quantify AFSCsphere-specific properties, like stemness and cell-cell interactions, in reaching enhanced therapeutic outcomes. - Source: PubMed
Publication date: 2026/07/09
Lu Shing-HwaHwang Shiaw-MinDubey Navneet KumarTsai Ming-SongYun Tien-FuLiao Jiunn-Wang - Immuno-metabolic dysregulation contributes to Alzheimer's disease (AD) pathogenesis, yet the peripheral metabolic landscape and its interplay with neuroinflammation remain poorly characterized in treatment-naïve, late-stage patients. This study aimed to delineate plasma metabolic alterations and immuno-metabolic interactions in Chinese first-time outpatients with late-onset AD (CFTO-LOAD). - Source: PubMed
Publication date: 2026/06/23
Wang Pei-JuanYang Xiao-YuJi LeiShi Jia-JiaCai Xiang-MingSun PengLiu He-XuJiang FeiYang Fan